Philips Medical Systems Gold Sponsor of the 2nd Gulf Nuclear Medical Conference

Philips Medical Systems is going to unveil a breakthrough positron emission tomography/computed tomography (PET/CT) system at the 2nd Gulf Nuclear Medicine. The GEMINI TF is the first PET system to use atomic particle time-measurements to deliver increased image quality and consistency, helping earlier disease detection in patients. The advantages of the technology have been previously demonstrated in a research environment, but Philips is the first healthcare technology provider to translate these benefits into a solution for consistent and reliable clinical use.

GEMINI TF is the world's first commercially available time-of-flight PET/CT system, in which gamma rays are more accurately tracked using minute time measurements. Raising effective image sensitivity by more than two times over conventional PET, the GEMINI TF delivers benefits for both patients and clinicians. Image acquisition is shortened to less than 10 minutes for a whole-body PET scan, even for larger patients, who had previously needed additional scan time. Consistent with all GEMINI PET/CT systems, GEMINI TF also features Philips patented OpenView gantry design, allowing for increased patient comfort.

"This addition to our broad portfolio demonstrates our technology leadership, and our ability to translate that expertise into clinical solutions which integrate seamlessly into the patient care cycle," said Diedrik Zeven, Philips Medical Systems General Manager Middle East Multi Country Region.

"GEMINI TF is a step-change for PET, delivering greatly improved performance and with it the possibility of earlier detection of disease and earlier treatment for patients in the future."

"Our company and the PET/CT team have been on a mission the past three years to deliver best in class clinical performance and enable Philips customers to provide best possible patient care. GEMINI TF is the fulfillment of that vision".

The combined benefits of faster sampling, longer useful imaging times from short-lived isotopes and the use of new low-efficiency tracers are set to significantly increase the utility of PET/CT for every healthcare stakeholder. The technology also opens the pathway to enable the molecular imaging applications of the future.